Biohealth Innovation - 312th Edition

BioHealth Innovation

If you are having trouble viewing this email, please click here

July 17, 2018

Local Biotech Firms Can Soon Apply for County Grants - Bethesda Beat - Bethesda, MD

Small biotech companies on Monday can start applying for matching grants from Montgomery County through a new program.

Could printable lungs solve transplant shortage? - Genetic Literacy Project

Recently I had the chance to hold a replica of the upper part of a human airway—the windpipe plus the first two bronchi. It had been made from collagen, the biological cement that holds our bodies together. It was slippery and hollow, with the consistency of undercooked pasta.

MedImmune and 4D Molecular Therapeutics Collaborate on AAV Gene Therapy for Lung Disease | BioSpace

AstraZeneca’s MedImmune and 4D Molecular Therapeutics forged a collaboration to develop a gene therapy for chronic lung disease.

Montgomery County Launches New Matching Grant Program to Help Grow Biotechnology Sector

Montgomery County companies may soon apply online for the County’s new Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Matching Grant Program. Applications will be accepted beginning at 10 a.m. on Monday, July 16.

MaxCyte Receives US FDA Investigational New Drug Clearance for First Clinical Program

MaxCyte announced that it has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to begin a clinical study in the United States with its first wholly-owned chimeric antigen receptor (CAR) therapeutic candidate, MCY-M11.

Altimmune Appoints Mitchel Sayare as Executive Chairman of the Board, and Adds José Ochoa to Its Leadership Team as Chief Business Officer - NASDAQ.com

Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on infectious disease, today announced it has appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board, effective immediately.

Baltimore biotech Elixirgen Therapeutics making drugs to target rare diseases, raises $4 million - Baltimore Business Journal

A Baltimore biotechnology company has raised $4 million, to help bring its therapeutic treatment targeting rare genetic diseases closer to market.

Clear Guide Medical gets $2M grant to develop tools for pediatrics - Technical.ly Baltimore

Johns Hopkins spinout Clear Guide Medical received a $2 million grant from the National Institutes of Health to apply its imaging tools to pediatrics.

WellDoc® Presents Results of an Innovative Economic Analysis Demonstrating Opportunity for Significant Healthcare Cost Savings with the Use of BlueStar® - WellDoc Inc

WellDoc®, a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital therapeutics, today announced results from an innovative economic analysis that demonstrated the potential for significant healthcare cost savings with the use of BlueStar®. BlueStar is powered by WellDoc and is a 510K-cleared digital therapeutic designed to coach adults with type 2 diabetes.

True Bearing Diagnostics Inc. raising millions to catch heart attacks before they strike - Washington Business Journal

True Bearing Diagnostics Inc. is working to commercialize an early-detection test for coronary artery disease, a possible game-changer for the health care industry.

Future Growth of Genomics Market by Global Industry Top 10 Players in The Globe with Thermo Fisher Scientific, Qiagen, Eurofins Scientific, F. Hoffmann-La Roche and More Till 2025 - openPR

The Worldwide Genomics Market report is an expert analysis report explore the market by Size, Share and Forecasts Till 2025. The Global Genomics Market size was estimated at USD 12.02 billion in 2016. It is anticipated to progress at a CAGR of 9.7% over the forecast period. Widening base of genomic data pool from genomic research activities is enabling physicians, biologists, and patients to further investigate genetic predisposition to certain diseases.

Johns Hopkins bioethics institute gets $15 million gift - Baltimore Business Journal

The chairman of Johns Hopkins University's Berman Institute of Bioethics has made a $15 million gift to establish a new endowment and support studying bioethicists.

PowerTen: Spend 10 Minutes with Baltimore’s Most Dynamic Innovation Leaders

Thursday, July 19, 20184:30 - 7:00 PM EST

Spend an inspiring 10 minute ‘ideastorming’ session with the Anchor Ventures PowerTen, the most influential innovation leaders in the greater Baltimore area – build on an idea for your company, bring your ideas for a program topic, a product, a system improvement or a better way to grow our ecosystem. Complete the RSVP link with your idea and we’ll match you to our PowerTen. Then mingle with more than 150 local entrepreneurs at our networking happy hour.

Summer Healthcare/Life Science Pitch Event: Sponsored by SoPE, CAAG and NIH

The Society of Physician Entrepreneurs and the MBA Collaborative Alumni Angel Group, in conjunction with NIH, cordially invite you to join us for our next meeting:

Summer Healthcare/Life Science Pitch Event

July 24th 2018 5 PM-8 PM

This program will be focused on start-up and emerging biotech, pharmaceutical, Health IT, and healthcare companies. Referrals are coming from NIH officials and consultants as well as SoPE/CAAG members and affiliates.

Call for Start-Ups; Please submit your Executive Summary and non-proprietary Slide deck to jhausfeld@sopenet.org for consideration to pitch at this upcoming event.

Amount of venture capital raised by Maryland companies increases 142 percent in 2Q - Baltimore Business Journal

Maryland companies raised $247 million in venture capital funding in the second quarter, the sixth consecutive quarter the state has raised at least $100 million.

Let's Talk Tech - #MoCo365

Want to hear more about cybersecurity and technology in Montgomery County? Check out the personal stories from our most innovative business leaders and entrepreneurs in the fields of IT, BioHealth, life sciences, and more.

Greater Washington VC drops in second quarter, PitchBook says - Washington Business Journal

Venture funding for Greater Washington companies fell nearly 50 percent in the second quarter from a year ago, but the region's take for the first half of the year remains above last year.

Restore the patent system and cut the red tape strangling federal labs

The National Institute of Standards and Technology issued a request for information seeking ideas for improving the public’s return on investment from federally supported R&D. Here’s my submission.

Gates Foundation’s $100M-a-year nonprofit biotech takes flight - FierceBiotech

The Bill & Melinda Gates Foundation has held a coming-out party for its nonprofit biotech startup. Equipped with plans to build a 120-person team and spend $100 million a year, the Gates Medical Research Institute (MRI) will turn drug industry expertise and processes on intractable diseases that kill millions of people annually in low- and middle-income countries.

An IPO drought? Why Greater Washington punches below its weight on Wall Street debuts - Washington Business Journal

The region has only seen one real initial public offering since the beginning of 2017.

As Amazon’s acquisition of PillPack sends shockwaves across the pharma industry, GlobalData publish their Top 25 Global Pharmaceutical Companies analysis by Market Cap | GlobalData Plc

The prospect of Amazon entering the pharma industry with the acquisition of PillPack will be a troubling development for pharma executives around the globe.

Can you find the hidden letter in this brainteaser? - Business Insider

This recently re-surfaced brainteaser has been making the rounds on the internet again. Apparently, reported Sharesplosion, if you can find the "C' that's hidden somewhere among the rows and rows of "Os" in under seven seconds, you're a genius (they claim that 99% of adults can't achieve this feat).

Alexandria Real Estate Equities, Inc. Expands Its First-in-Class New York City Regional Life Science Cluster Franchise with the Strategic Acquisition of 219 East 42nd Street in Manhattan, Subject to a Leaseback | STL.News

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, today announced it has acquired 219 East 42nd Street for $203 million on a fee simple basis, through a membership interest in the purchasing entity 219/235 East LLC. As part of the transaction, 219/235 East LLC leased back 219 East 42nd Street on a triple net basis to Pfizer Inc., which announced earlier this year plans to relocate its global office headquarters to Manhattan’s Hudson Yards neighborhood in 2022. Ideally located in the heart of Manhattan’s East Side Medical Corridor with critical adjacency to New York City’s renowned academic and medical institutions, the acquisition of this approximately 350,000 RSF, 10-story office building represents significant and immediate net operating income growth with a strong yield from an investment-grade tenant.

Executive Compensation at Private and Public Colleges - The Chronicle of Higher Education

The Chronicle‘s executive-compensation package includes the latest data on more than 1,400 chief executives at more than 600 private colleges from 2008-15 and nearly 250 public universities and systems from 2010-17. Hover over bars to show total compensation as well as pay components including base, bonus, and other.